Fiscal Receipts

Senate LDA lobbying filing

Pfizer Inc

A public disclosure record: who filed, what they reported, and the program connections found in the text.
Reported amountsProgram mentionsActivity textLobbyists
Registrant: Altrius Group, LLC Year: 2024 Period: First Quarter Type: Q1

Filed as: PFIZER INC — ALTRIUS GROUP, LLC. Search lda.senate.gov for those strings; the names above are this site’s casing of them, nothing else.

View on lda.senate.gov ↗

Reported income

$20.0K

Reported expenses

not reported

Connections in the record

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

  • Promotion and Protection Strategies0602128D8Zmatched: “Promotion|Protection”matched 2+ title words

    Compulsory licensing of US IP by foreign governments; WTO Covid TRIPS waiver proposal; Promotion of robust IP…

Lobbying activities1

  • Trade (domestic/foreign)TRD

    Compulsory licensing of US IP by foreign governments; WTO Covid TRIPS waiver proposal; Promotion of robust IP protection for biopharma innovations before WTO and in current and future FTAs

Lobbyists1

  • WILLIAM MORLEYrevolving door

    General Counsel US Senator Arlen Specter

Source: U.S. Senate Lobbying Disclosure Act database. Underlined dollar figures cite the filing record on lda.senate.gov and open to that citation. Amounts shown as “not reported” are absent from the filing itself.